Back to top
more

Elevance Health, Inc. (ELV)

(Delayed Data from NYSE)

$540.01 USD

540.01
650,835

-0.42 (-0.08%)

Updated Jun 5, 2024 04:00 PM ET

After-Market: $540.01 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (87 out of 248)

Industry: Medical Services

Better trading starts here.

Zacks News

Cigna's (CI) Medicare Advantage Unit Draws Acquisition Interest

The final bids for Cigna's (CI) Medicare Advantage unit are expected next week.

Here's Why Investors Should Hold Elevance (ELV) Stock for Now

Elevance's (ELV) Carelon unit will see growth due to improving performance in post-acute care services and Behavioral Health business.

Elevance Health (ELV) Rises Yet Lags Behind Market: Some Facts Worth Knowing

In the latest trading session, Elevance Health (ELV) closed at $488.06, marking a +0.94% move from the previous day.

Why Elevance Health (ELV) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Elevance Health (ELV) Stock Slides as Market Rises: Facts to Know Before You Trade

Elevance Health (ELV) closed the most recent trading day at $476.96, moving -0.28% from the previous trading session.

Elevance Health (ELV) Outperforms Broader Market: What You Need to Know

Elevance Health (ELV) concluded the recent trading session at $483.12, signifying a +0.76% move from its prior day's close.

Kaibalya Pravo Dey headshot

Analyzing Cigna & Humana Merger Talks: Opportunities & Obstacles

The Cigna-Humana merger will provide the combined body with increased negotiation power with healthcare providers, pharmaceutical companies and other stakeholders.

Here's Why Elevance Health (ELV) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Why Is Teladoc (TDOC) Down 2.1% Since Last Earnings Report?

Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

The Zacks Analyst Blog Highlights Procter & Gamble, Novartis, Mondelez International, Elevance Health and Vertex Pharmaceuticals

Procter & Gamble, Novartis, Mondelez International, Elevance Health and Vertex Pharmaceuticals are part of the Zacks top Analyst Blog.

Mark Vickery headshot

Top Stock Reports for Procter & Gamble, Novartis & Mondelez International

Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Company (PG), Novartis AG (NVS) and Mondelez International, Inc. (MDLZ).

Why Is Elevance Health (ELV) Up 0.1% Since Last Earnings Report?

Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Cigna (CI) Unit Unveils Pricing Model for Pharmacy Clients

Cigna's (CI) sub-unit Express Scripts introduces a pricing option for prescription drugs that may bolster the customer base and fetch higher pharmacy revenues to the health insurer.

3 Reasons Why Growth Investors Shouldn't Overlook Elevance Health (ELV)

Elevance Health (ELV) possesses solid growth attributes, which could help it handily outperform the market.

ELV or AMEH: Which Is the Better Value Stock Right Now?

ELV vs. AMEH: Which Stock Is the Better Value Option?

Why Elevance Health (ELV) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Tenet Healthcare (THC) Q3 Earnings Beat on Solid Ambulatory Care

Tenet Healthcare's (THC) Q3 results gain on improved adjusted admissions and higher pricing yield. Management expects adjusted EPS of $5.43-$6.05 for 2023.

Encompass Health's (EHC) Q3 Earnings Beat on Discharge Growth

Encompass Health's (EHC) Q3 results benefit from an increase in patient volumes and net patient revenue per discharge. Management currently projects adjusted EPS to be within $3.41-$3.52 for 2023.

ELV vs. HQY: Which Stock Is the Better Value Option?

ELV vs. HQY: Which Stock Is the Better Value Option?

DexCom (DXCM) Beats on Q3 Earnings, Raises Sales Outlook

DexCom's (DXCM) third-quarter 2023 results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.

CONMED (CNMD) Beats on Q3 Earnings, Ups '23 EPS View

CONMED's (CNMD) adjusted third-quarter earnings and sales beat estimates on the back of strong growth in the U.S and international markets. Gross margin improves.

West Pharmaceutical (WST) Beats on Q3 Earnings, HVP Drives Sales

West Pharmaceutical's (WST) third-quarter results reflect a strong demand for non-COVID-19 demand, especially HVP devices.